Exploring the role of gut microbiota in inflammatory bowel disease patients comorbid with non-alcoholic fatty liver disease
Our findings implicate microbiota-mediated metabolic reprogramming in IBD-associated NAFLD pathogenesis, highlighting potential therapeutic targets for the treatment and prevention of NAFLD in IBD.
Authors
- Liping Duan (ORCID: https://orcid.org/0000-0001-6886-6888)
- Jiachen Hu (ORCID: https://orcid.org/0000-0002-0562-8986)
- Jun Li (ORCID: https://orcid.org/0000-0003-3519-8638)
- Lu Zhang (ORCID: https://orcid.org/0000-0002-0787-2595)
- Junxia Li (ORCID: https://orcid.org/0000-0001-5191-3166)
- Yuzhu Chen (ORCID: https://orcid.org/0000-0002-6445-8489)
- Chen Zhou (ORCID: https://orcid.org/0009-0009-1510-0315)
Institutions
- Peking University (CN)
- Chinese PLA General Hospital (CN)
- Peking University First Hospital (CN)
- Peking University Third Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- Gut Pathogens
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1186/s13099-025-00752-x
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China